Matthew Greenhawt

Corporate Officer/Principal bei Intrommune Therapeutics, Inc.

Miscellaneous

Aktive Beziehungen

Name	Geschlecht	Alter	Unternehmensverbindungen	Zusammenarbeit
Michael Nelson	M	-	Intrommune Therapeutics, Inc. Intrommune Therapeutics, Inc. MiscellaneousMiscellaneous Intrommune Therapeutics, Inc. operates as a biopharmaceutical company. The firm develops oral mucosal immunotherapy(OMIT) platform for food allergies. The company was founded by Michael Nelson and William Reisacher in 2015 and is headquartered in New York, NY.	9 Jahre
William Reisacher	M	-	Intrommune Therapeutics, Inc. Intrommune Therapeutics, Inc. MiscellaneousMiscellaneous Intrommune Therapeutics, Inc. operates as a biopharmaceutical company. The firm develops oral mucosal immunotherapy(OMIT) platform for food allergies. The company was founded by Michael Nelson and William Reisacher in 2015 and is headquartered in New York, NY.	-
Stuart Loesch	M	-	Intrommune Therapeutics, Inc. Intrommune Therapeutics, Inc. MiscellaneousMiscellaneous Intrommune Therapeutics, Inc. operates as a biopharmaceutical company. The firm develops oral mucosal immunotherapy(OMIT) platform for food allergies. The company was founded by Michael Nelson and William Reisacher in 2015 and is headquartered in New York, NY.	3 Jahre
Alain van Loo	M	-	Intrommune Therapeutics, Inc. Intrommune Therapeutics, Inc. MiscellaneousMiscellaneous Intrommune Therapeutics, Inc. operates as a biopharmaceutical company. The firm develops oral mucosal immunotherapy(OMIT) platform for food allergies. The company was founded by Michael Nelson and William Reisacher in 2015 and is headquartered in New York, NY.	3 Jahre
Rena Rosenberg	M	-	Intrommune Therapeutics, Inc. Intrommune Therapeutics, Inc. MiscellaneousMiscellaneous Intrommune Therapeutics, Inc. operates as a biopharmaceutical company. The firm develops oral mucosal immunotherapy(OMIT) platform for food allergies. The company was founded by Michael Nelson and William Reisacher in 2015 and is headquartered in New York, NY.	4 Jahre